Menu

Press Releases

Varian Medical Systems Exhibits New Flat-Panel Digital X-ray Image Detectors Designed for High Energy Industrial and Security Applications

, , , , ,

Varian showcasing these and other X-ray imaging components at the 2013 Transport Security (TranSec) Expo in London this week LONDON, Nov. 14, 2013 /PRNewswire/ — A new flat-panel digital X-ray image detector designed especially for use in high-energy industrial and security imaging systems is among the imaging components that Varian Medical Systems (NYSE:VAR) is exhibiting at the 2013 […]

Novartis announces positive clinical trial results for novel H7N9 vaccine

, ,

85% of subjects immunologically protected after receiving second dose of investigational cell culture vaccine when combined with proven MF59® adjuvant Vaccine now in large scale production highlighting rapid response capability of novel FDA licensed cell culture technology 135 confirmed cases and 45 deaths from H7N9 virus since emergence in March according to the World Health […]

Walgreens Studies Demonstrate Success of HIV-Specialized Pharmacies in Improving Patient Medication Adherence

,

Company presents study findings at Cell-Lancet HIV/AIDS conference DEERFIELD, Ill., November 12, 2013 – Walgreens (NYSE: WAG) (Nasdaq: WAG) recently presented research from two retrospective cohort studies exploring HIV and comorbid medication adherence at HIV-specialized pharmacies and the implications for HIV patients with serious mental illness1. The research, presented at the Cell-Lancet conference, What Will […]

Sangamo BioSciences Announces Presentation Of First Demonstration Of In Vivo Efficacy Of Novel ZFP Therapeutic® For Huntington’s Disease

, , ,

Approach Selectively Represses Only the Disease-Causing Gene Resulting in Statistically Significant Effects on Symptoms and Other Biomarkers of Disease in Animal Models RICHMOND, Calif., Nov. 12, 2013 /PRNewswire/ — Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that positive preclinical data from their joint program with Shire plc to develop a novel ZFP Therapeutic® approach to Huntington’s disease (HD) were presented […]

Cardinal Health Foundation Calls for Applicants for Patient Safety Grants

, ,

E3 Grant Program helps health care institutions improve effectiveness, efficiency and excellence DUBLIN, Ohio, Nov. 11, 2013 /PRNewswire/ — The Cardinal Health Foundation is currently accepting applications for grant funding to help U.S., Canadian and Puerto Rican hospitals, health systems, community health clinics and other non-profit health care institutions improve the efficiency and quality of […]

MERZ PHARMA GROUP ACQUIRES SWISS AESTHETICS COMPANY ANTEIS S.A.

, ,

GREENSBORO, N.C. – BUSINESS WIRE – Merz Pharma Group (Frankfurt am Main) announced that it has entered into a definitive agreement to acquire Anteis S.A., a Swiss company which specializes in the development, manufacture and commercialization of medical devices in the area of aesthetics. With products available in more than 90 countries on five continents, Anteis has been recognized as […]

Novartis announces divestiture of its blood transfusion diagnostics unit to Grifols

, ,

Spain-based Grifols to acquire Novartis blood transfusion diagnostics unit for USD 1.675 billion Divestiture further enhances Novartis focus on strategic businesses Basel, November 11, 2013 – Novartis announced a definitive agreement to divest its blood transfusion diagnostics unit to Grifols for USD 1.675 billion. This transaction, requiring customary regulatory approvals, is expected to be completed […]

Forest Laboratories Names A. Robert D. Bailey Senior Vice President, Chief Legal Officer and General Counsel

, , ,

NEW YORK–November 11, 2013–(BUSINESS WIRE)–Forest Laboratories, Inc. (NYSE:FRX) today announced that Robert Bailey was appointed Senior Vice President, Chief Legal Officer General Counsel. In this role, Bailey will be responsible to manage the legal affairs of the Company, and will also serve as the company’s Corporate Secretary. Bailey will report to Brent Saunders, Chief Executive […]

Two Papers From a Large Multi-site Study Further Demonstrate Efficacy and Quality of Life Benefits for Prostate Cancer Patients Treated with Accuray’s CyberKnife® System

, , , ,

UCLA Researchers Evaluate Long-term Outcomes of More than 1,000 Patients from Multiple Institutions SUNNYVALE, Calif., November 7, 2013 – Accuray Incorporated (Nasdaq: ARAY), announced today the publication of two papers stemming from a large multi-center study of CyberKnife® stereotactic body radiotherapy (SBRT) led by investigators at the University of California, Los Angeles (UCLA). The first […]

Forest Laboratories, Inc. Announces Settlement of BYSTOLIC® Patent Litigation

, , ,

NEW YORK–November 7, 2013–(BUSINESS WIRE)–Forest Laboratories, Inc. (NYSE:FRX) and Forest Laboratories Holdings, Ltd. (collectively, “Forest”) announced today that they have entered into a settlement agreement with Actavis, Inc. and related companies and subsidiaries thereof, in patent infringement litigation brought by Forest in response to Actavis’s abbreviated new drug application (“ANDA”) seeking approval to market generic […]

«‹ 37 38 39 40›»